We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks & Spencer Regulatory News (MKS)

Share Price Information for Marks & Spencer (MKS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 254.50
Bid: 253.90
Ask: 254.10
Change: -1.30 (-0.51%)
Spread: 0.20 (0.079%)
Open: 255.70
High: 257.90
Low: 252.10
Prev. Close: 255.80
MKS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

12 Sep 2016 15:37

RNS Number : 5983J
Marks & Spencer Group PLC
12 September 2016
 

 

 

 

Issued: 12 September 2016

Marks and Spencer Group plc announces

the departure of Laura Wade-Gery

 

M&S today announces that it has agreed with Laura Wade-Gery that, following her maternity leave, Laura will not be returning to her position as Executive Director, Multi-Channel, and will be leaving the company at the end of September. Laura will step down from the Board with immediate effect. There are no further changes to the previously announced responsibilities covering her maternity.

 

Commenting on the announcement, Robert Swannell, Chairman of Marks and Spencer Group plc, said: "On behalf of the Board, I would like to thank Laura very much for the significant contribution she has made in her five years at M&S. Laura has been a valued member of the Board and instrumental in the improvement and modernisation of our ecommerce and multi-channel capabilities. We wish her all the very best for the future."

 

Steve Rowe, Chief Executive, said: "Laura has been a great colleague and has achieved much in her role heading our multi-channel business. I am grateful to Laura for her contribution and she leaves M&S with my personal thanks and best wishes."

 

Laura Wade-Gery said: "I have had five very happy years at M&S. I've been away from the business for a year now, and that time has seen some significant changes in both my personal life and in the business. I concluded that the time was right to move on from M&S. I wish Steve and all my colleagues and friends every success".

 

Remuneration:

The following information is provided in accordance with section 430(2B) of the Companies Act 2006:

· Laura Wade-Gery's remuneration terms will be in line with the key provisions for contract termination as per Marks and Spencer Group plc's Executive Remuneration Policy approved by shareholders in 2014.

· Laura will receive monthly payments of up to a maximum of eight months' salary and benefits, subject to mitigation.

· Any unvested nil-cost options awarded to Laura Wade-Gery under the Deferred Share Bonus Plan will vest in full on termination and may then be exercised in accordance with the Plan rules.

· Any unvested nil-cost options awarded under the Performance Share Plan will be time pro-rated and will vest, subject to performance conditions on a wait and see basis at the normal vesting date and may then be exercised in accordance with the Plan rules.

· Laura Wade-Gery will not be eligible to participate in the Annual Bonus or Performance Share Plan awards for 2016/17.

· Further details of the operation of the Deferred Share Award and Performance Share Plan are set out in the Directors' Remuneration Report in our Annual Report and Financial Statements 2016. Full disclosure of these remuneration arrangements will be provided in our Directors' Remuneration Report in 2017.

 

- Ends -

 

For further information, please contact:

Corporate Press Office: +44 (0)20 8718 1919

Out of hours calls: +44 (0)20 8718 2000

 

Investor Relations:

Fraser Ramzan +44 (0)20 8718 4625

Helen Cox +44 (0)20 8718 8491

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGMLDZVGVZM
Date   Source Headline
1st May 20249:00 amRNSTotal Voting Rights
30th Apr 20241:13 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:00 amRNSTotal Voting Rights
28th Mar 20245:23 pmRNSHolding(s) in Company
28th Mar 20243:07 pmRNSDirector/PDMR Shareholding
26th Mar 20243:07 pmRNSDirector/PDMR Shareholding
7th Mar 20243:16 pmRNSHolding(s) in Company
7th Mar 20248:40 amRNSKatie Bickerstaffe - Planned Leadership Evolution
4th Mar 20243:11 pmRNSDirector/PDMR Shareholding
1st Mar 20249:00 amRNSTotal Voting Rights
28th Feb 20241:43 pmRNSDirector/PDMR Shareholding
16th Feb 20249:00 amRNSDirector Declaration
1st Feb 20249:00 amRNSTotal Voting Rights
30th Jan 20242:53 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
15th Jan 20242:36 pmRNSHolding(s) in Company
11th Jan 20247:00 amRNSChristmas 2023/2024 Trading
10th Jan 20243:28 pmRNSChange To Board Committee Membership
5th Jan 20244:23 pmRNSHolding(s) in Company
2nd Jan 20249:00 amRNSTotal Voting Rights
2nd Jan 20249:00 amRNSBlock listing Interim Review
28th Dec 202311:40 amRNSDirector/PDMR Shareholding
20th Dec 202311:36 amRNSHolding(s) in Company
19th Dec 202310:30 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSAdditional Listing
12th Dec 20239:13 amRNSDirector/PDMR Shareholding
1st Dec 20239:00 amRNSTotal Voting Rights
28th Nov 20232:55 pmRNSDirector/PDMR Shareholding
9th Nov 202310:29 amRNSDirector/PDMR Shareholding
8th Nov 20237:00 amRNSHalf-year Report
1st Nov 20239:00 amRNSTotal Voting Rights
30th Oct 20235:01 pmRNSDirector/PDMR Shareholding
2nd Oct 20239:00 amRNSTotal Voting Rights
28th Sep 20233:18 pmRNSDirector/PDMR Shareholding
20th Sep 20233:33 pmRNSHolding(s) in Company
20th Sep 20239:00 amRNSDirector/PDMR Shareholding
19th Sep 20239:01 amRNSDirector/PDMR Shareholding
1st Sep 20239:00 amRNSTotal Voting Rights
30th Aug 202310:34 amRNSDirector/PDMR Shareholding
16th Aug 20233:00 pmRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSTrading Update and Outlook for the Year
1st Aug 20239:00 amRNSTotal Voting Rights
28th Jul 202311:33 amRNSDirector/PDMR Shareholding
7th Jul 20234:18 pmRNSDirector/PDMR Shareholding
4th Jul 20232:13 pmRNSResult of AGM
3rd Jul 20239:00 amRNSTotal Voting Rights
3rd Jul 20239:00 amRNSBlock listing Interim Review
28th Jun 20232:01 pmRNSDirector/PDMR Shareholding
19th Jun 20234:41 pmRNSDirector/PDMR Shareholding
8th Jun 20235:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.